Honghui Hu

Partner Wanhuida Intellectual Property

+86 10 6892 1000

Contact

Published by this author:

Features

Sponsored by Wanhuida Intellectual Property

How does pharmacological action affect the defence of a pharmaceutical compound patent in China?

Honghui Hu of Wanhuida Intellectual Property explains that a CNIPA ruling on a patent covering an antidepressant could help to determine the patentability of pharmaceutical compounds

Honghui Hu, June 22, 2023
Sponsored by Wanhuida Intellectual Property

A reverse payment settlement agreement under antitrust scrutiny of China’s SPC

Jianhui Li and Honghui Hu of Wanhuida Intellectual Property discuss the antitrust scrutiny of China’s Supreme People’s Court in a patent infringement appeal concerning reverse payment settlement agreement

Honghui Hu, May 24, 2022
Sponsored by Wanhuida Intellectual Property

The structure-activity relationship and pharmaceutical compounds

Honghui Hu of Wanhuida Intellectual Property considers the impact of the structure-activity relationship on the inventiveness assessment of pharmaceutical compounds

Honghui Hu, September 16, 2021